Ep. 65: Software Development Consulting - Sam Schutte (CEO Unstoppable Software)

Sam Schutte is the founder and CEO of Unstoppable Software, Inc. (https://unstoppablesoftware.com), a custom software development company that helps clients build systems to automate workflow and implement digital transformation. We talked about the challenges his clients face in an ever-changing technology landscape. Special intro on Racial Injustice by Police Visit for more information: https://blacklivesmatter.com/resources/ Disclaimer: Remember, the Health Unchained podcast is for informational and entertainment purposes only and we are not providing any sort of legal, financial, or medical advice. Please do your own research and due diligence before making any important decisions related to these matters. Show Notes •Intro to Sam's background •Unstoppable Software and services •Managing Data Liability •In your experience, what are the biggest challenges and opportunities for blockchain adoption in healthcare? •Impact of COVID19 •Blockchain opportunities for foster care industry •Decision making process to buy/build enterprise software •C based programming Languages •Microsoft and .NET on Linux •EHR development and deployment experience •Industry Trends in software development and the acceleration of open source •Pros/Cons of Off-shoring development work •If it’s not too personal, what would you consider to be your biggest mistake? •Early Bitcoin mining •Have you changed your mind on anything recently and what made you change it? •If you had to have a micro chip implanted in your body, where would you want it to be implanted? •What do you do during your free time? •Final takeaways Health Unchained News Corner https://www.bioworld.com/articles/435382-kahala-biosciences-rymedi-bring-blockchain-to-covid-19-antibody-testing Kahala Biosciences LLC, a California based COVID19 testing distribution startup and Rymedi Inc, a blockchain technology company based in Greenville SC have partnered to launch the Adiona COVID19 antibody testing platform. Francis Duhay, Kahala’s CEO said “The ultimate vision is for people to employ both viral antigen and antibody testing at home.” The ADIONA Platform is currently under Clinical Investigation and Not Yet Approved By FDA. The COVID-19 IgG/IgM tests are not approved by FDA and are currently undergoing Emergency Use Authorization (EUA) review. I hope this vision becomes reality as it would be a great solution to our current lack of COVID19 testing. I’m sure the details of the platform are still being worked on but this is a step in the right direction. I’ll be following this partnership closely. Health Unchained Links Website: https://healthunchained.org Telegram: t.me/healthunchained Twitter: twitter.com/Healthunchaind Bert’s Blockchain and Healthcare Weekly Newsletter: https://bert.substack.com/